{
  "docId": "019de073-b144-743c-94c4-bc5a80eb44df",
  "docSlug": "9540d42c57dd536e8cb82c97bd211004",
  "documentTitle": "Dare Bioscience | Investor Presentation Deck | 50 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 29,
  "pageCount": 50,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "Includes specific clinical data points from a Postcoital Test (PCT) study.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-b144-743c-94c4-bc5a80eb44df/29",
  "deckHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df",
  "deckJsonHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df.json",
  "deckAnchorHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.51,
        "y": 0.15
      },
      "kind": "callout",
      "text": "The PCT Clinical Study Met its Primary Endpoint. Ovaprene prevented the requisite number of sperm from reaching the cervix across all women and all cycles evaluated.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7c95757-69e8-4718-9ccd-7d62d3272b04",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.43,
        "x": 0.04,
        "y": 0.42
      },
      "kind": "paragraph",
      "text": "Step 2 (Ongoing) 1 - FDA approval of investigational device exemption (IDE) for pivotal study start – Obtained 4Q-2022 2 - Review and implement additional FDA study design recommendations 3 - Conduct pivotal study – Recruitment initiation mid-2023",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "121a8a26-0691-4821-b5ca-368b78aaa951",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.43,
        "x": 0.04,
        "y": 0.14
      },
      "kind": "paragraph",
      "text": "Premarket approval (PMA) strategy – The Center for Devices and Radiological Health (CDRH) as lead review division",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3391b15b-1785-444d-8d13-884547f4e4c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.43,
        "x": 0.04,
        "y": 0.025
      },
      "kind": "paragraph",
      "text": "Step 1 (Completed) Postcoital Test (PCT) Clinical Study - Completed 4Q 2019",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ded0126-53d8-4bf7-a899-0162437a55ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.01,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1.Anticipated regulatory pathway and timelines. 2.Mauck C., Vincent K. Biology of Reproduction, Volume 103, Issue 2, August 2020, Pages 437-444",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad419fe9-9133-4460-b429-b5cf254dcc0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.38,
        "x": 0.55,
        "y": 0.058
      },
      "kind": "table",
      "text": "Baseline PCT's vs Ovaprene PCT's data table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd0a4536-bd89-4f36-93d5-b095c7abb741",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.46,
        "x": 0.27,
        "y": 0.03
      },
      "kind": "title",
      "text": "Ovaprene - U.S. Regulatory Strategy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7cb8f7fd-ec2d-4bf8-abdf-3797e521b62b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "68df505a-0fd6-4011-b7cd-66c57555abc3",
      "evidence": "Baseline PCT's vs Ovaprene PCT's data table",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}